Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-05-01
著者
-
永井 正
自治医科大学内科学講座血液学部門
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
永井 正
自治医科大学 内科学講座血液学部門
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
Nagai Tadashi
東京慈恵会医科大学 内科学講座血液内科
-
Nagai Tadashi
Division Of Hematology Department Of Medicine Jichi Medical University
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
NAKASEKO Chiaki
Chiba University Hospital
-
AMAGASAKI Taro
Novartis Pharma Japan
-
Nakaseko Chiaki
Department Of Clinical Cell Biology And Medicine Chiba University Graduate School Of Medicine
-
Kamiya Yoshikazu
Department Of Hematology Meitetsu Hospital
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Okayama Kenichi
Department Of Internal Medicine Iii Hamamatsu University School Of Medicine
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Ohshima Koichi
First Department Of Pathology Fukuoka University
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Matsuo Yuji
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Tomita Akihiro
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Maruta Atsuo
Department Of Hematology Kanagawa Cancer Center
-
Maruta A
Kanagawa Cancer Center Yokohama City Jpn
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Kurokawa Mineo
Department Of Hematology And Oncology University Of Tokyo
-
Masaki Y
Department Of Hematology And Immunology Kanazawa Medical University
-
Morishita Yoshihisa
Department Of Hematology And Oncology Ja Aichi Showa Hospital
-
Morita Yasuyoshi
Kinki Univ. School Of Medicine Osaka Jpn
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Nakamae Hirohisa
Hematology Graduate School Of Medicine Osaka City University
-
Ohnishi Kazunori
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Morishita Yasuyuki
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
Oncology Center Hamamatsu University School Of Medicine
-
Ochi Kensuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Tadashi Nagai
Division Of Hematology Department Of Medicine Jichi Medical University
-
Ohhashi Kyoichi
Department Of Clinical Pharmacology And Therapeutics Hamamatsu University School Of Medicine
-
Yasukawa Masaki
Department Of Bioregulatory Medicine Ehime University
-
Kanda Yoshinobu
Division Of Hematology And Oncology Okayama University Hospital
-
Miki Yoshio
Department Of Human Genome Analysis Cancer Chemotherapy Center Japanese Foundation For Cancer Resear
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Takeshita Akihiro
Hamamatsu Univ. School Of Medicine Shizuoka Jpn
-
Shibayama Hirohiko
Department Of Hematology/oncology Osaka University Graduate School Of Medicine
-
Fukuda Tetsuya
Department Of Chemistry Graduate School Of Science Tohoku University
-
Matsuda Akira
Department Of Applied Chemistry Ehime University
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Kashiwagi Yoichiro
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Maeda Yasuhiro
Department Of Applied Physics Tokyo Institute Of Technology
-
Fukuda Tetsuya
Department Of Hematology Tokyo Medical And Dental University Hospital Of Medicine
-
YANADA Masamitsu
Novartis Pharma KK
-
Kaji Yoshikazu
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kurokawa Mineo
Department Of Hematology And Oncology The University Of Tokyo Hospital
-
Nakamae Hirohisa
Hematology Osaka City University Hospital
-
Shibayama Hirohiko
Department Of Hematology And Oncology Osaka University Hospital
-
Ohnishi Kazunori
Shikoku National Hospital Matsuyama Jpn
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Mikami Yuzuru
Department Of Hematology And Cell Therapy Aichi Cancer Center Hospital
-
Kurokawa Mineo
Department Of Hematology And Oncology Graduate School Of Medicine The University Of Tokyo
-
Kurokawa Mineo
Department of Hematology & Oncology, The University of Tokyo
-
KUROKAWA Mineo
Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo
-
MAEDA Yasuhiro
Department of Agricultural Chemistry, College of Agriculture, University of Osaka Prefecture
-
Nagai Tadashi
Division of Cell Therapy, Jichi Medical University Hospital, Shimotsuke
関連論文
- 白血病 (特集 分子標的薬治療--癌から他疾患までの治癒をめざして) -- (疾患別分子標的薬治療の現状と今後の展望 悪性腫瘍)
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- IL-21受容体細胞外ドメインを用いた移植片対宿主病治療の可能性(平成18年度自治医科大学医学部研究奨励金研究成果報告)
- 骨髄非破壊的同種骨髄移植後にサイトメガロウイルス網膜炎を発症した成人T細胞白血病
- 8p11関連の染色体異常を伴わない
- 当科における成人ALLに対する地固め療法としてのHyper-CVAD/High-dose MTX-Ara-C療法の治療成績
- 特発性血小板減少性紫斑病に対する Helicobacter pylori 除菌療法 : Helicobacter pylori の活動性と血小板数との相関
- 骨髄壊死による膝関節痛が先行出現した minor bcr/abl キメラ遺伝子陽性急性リンパ性白血病
- 難治性移植片対宿主病に対する mycophenolate mofetil の有用性
- 19.異所性肺石灰化をきたした成人T細胞白血病の1例(第111回日本呼吸器内視鏡学会関東支部会)
- 消化管B細胞性リンパ腫患者から得られた内視鏡生検検体のフローサイトメトリーを用いた評価
- B細胞起源と診断した血管免疫芽球性リンパ腫
- フローサイトメトリーを用いたB細胞性リンパ腫における骨髄浸潤評価の臨床的意義
- 当科におけるbiphenotypic acute leukemia 8例の治療成績
- Mycophenolate mofetil が有効であった HLA 1 座不一致母児間末梢血幹細胞移植後の難治性急性移植片対宿主病
- 形質細胞様樹状細胞由来の悪性リンパ腫
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- 症例報告 輸血後鉄過剰症に対するICL670(deferasirox)投与により造血能の回復が得られた骨髄異形成症候群
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- All-trans retinoic acid投与中にレチノイン酸症候群を併発し急性心筋梗塞および脳梗塞を生じた急性前骨髄球性白血病
- 輸血後鉄過剰症に対する ICL670 (deferasirox) 投与により造血能の回復が得られた骨髄異形成症候群
- 急性白血病の寛解導入における血小板輸血トリガー値の検討
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- 壊疽性膿瘡を伴う緑膿菌敗血症を合併した急性骨髄性白血病
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- 2'-deoxycoformycinが奏功したhairy cell leukemia prolymphocytic variant
- 2'-deoxycoformycinが奏功したhairy cell leukemia prolymphocytic variant
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Case-control study of leukemia and diagnostic radiation exposure
- 慢性骨髄性白血病に対する分子標的治療の動向
- Successful cord blood transplantation for mycosis fungoides.
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- 薬物療法 多剤併用化学療法 (特集 骨髄性白血病--病因・治療研究の進歩) -- (治療法の進歩)
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Maintenance and preemptive therapy with ganciclovir for cytomegalovirus colitis with extremely high antigenemia in adult T-cell leukemia
- Sperm cryopreservation in patients with hematologic malignancies
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Genetic Diagnosis of Community-Acquired MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome mec Typing and Detecting Toxin Genes
- Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- フローサイトメトリを用いて骨髄移植後の微小残存病変を検出した急性骨髄性白血病
- 急性GVHDの補助的検査:granzyme Bおよびperforin細胞内染色の有用性
- 骨髄移植後にB型劇症肝炎を発症した急性骨髄性白血病の一例
- 当科におけるバーキットリンパ腫/白血病治療成績の向上
- Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
- イマチニブに対して Late Suboptimal Response を示した慢性期CML症例に対する治療選択
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- AA amyloidosis associated with macroglobulinemia
- IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Clinical Features of Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- IgG4-related disease : Historical overview and pathology of hematological disorders
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
- Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- In vivo efficacy of doripenem (DRPM) against Pseudomonas aeruginosa in murine chronic respiratory tract infection model.
- Clinical Characteristics of Seven Patients with Aeromonas Septicemia in a Japanese Hospital
- ステロイド抵抗性移植片対宿主病に対する間葉系幹細胞を用いた新規治療のパイロット試験
- Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- MDSの最新治療 (MDS(骨髄異形成症候群))
- Autologous Hematopoietic Recovery with Aberrant Antigen Expression after Allogeneic Bone Marrow Transplantation
- Prediction of Progression from Refractory Cytopenia with Unilineage Dysplasia by Analysis of Bone Marrow Blast Cell Composition